Psychosocial factors: Role in cardiac risk and treatment strategies

Cardiology Clinics

Volumn 14, Issue 1, 1996, Pages 97-104

  Williams, R B ^a   Littman, A B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN AGONIST; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CARDIOTOXICITY; DEPRESSION; EMOTIONAL STRESS; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOCIOECONOMICS;

EID: 0030020224     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70263-0     Document Type: Article

References (59)

1. J.C. Barefoot Type A behavior and survival: A follow-up study of 1467 patients with coronary artery disease Am J Cardiol 64 1989 427
2. L.F. Berkman Emotional support and survival following myocardial infarction: Findings from a prospective population-based study of the elderly Ann Intern Med 117 1992 1003
3. J.A. Blumenthal Task Force III: Assessment of psychological status in patients with ischemic heart disease J Am Coll Cardiol 14 1989 1034
4. R.M. Carney The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease J Psychosom Res 32 1988 159
5. R.B. Case Living alone after myocardial infarction: Impact on prognosis JAMA 267 1992 515
6. N.H. Cassem Cardiovascular effects of antidepressants J Clin Psychiatry 43 1982 22
7. E. Coccaro Central serotonin and impulsive aggression Br J Psychiatry 155 1989 52
8. G.L. Cooper The safety of fluoxetine: An update Br J Psychiatry 153 1988 77
9. J.E. Dimsdale Effects of chronic stress on beta-adrenergic receptors in the homeless Psychosom Med 56 1994 290
10. M. Fava J.F. Rosebaum J.A. Pava Anger attacks in unipolar depression: Part I. Clinical correlates and response to fluoxetine treatment Am J Psychiatry 150 1993 1158 1163
11. R. Fleming Mediating influences of social support on stress at Three Mile Island J Hum Stress 8 1982 14
12. N. Frasure-Smith In-hospital symptoms of psychological distress as predictors of long-term outcome after acute myocardial infarction in men Am J Cardiol 67 1991 121
13. N. Frasure-Smith R. Prince The Ischemic Heart Disease Life Stress Monitoring Program: Impact on mortality Psychosom Med 47 1985 431
14. N. Frasure-Smith Depression following myocardial infarction: Impact on 6-month survival JAMA 270 1993 1819
15. Frasure-Smith Depression and 18-month prognosis after myocardial infarction Circulation 91 1995 999
16. G.I. Fricchione Vasoconstrictive effects and SSRIs J Clin Psychiatry 54 1993 71
17. M. Friedman Alteration of type A behavior and its effect on cardiac recurrences in post-myocardial infarction patients: Summary results of the Recurrent Coronary Prevention Project Am Heart J 112 1986 653
18. S. Fukudo Accentuated vagal antagonism of beta-adrenergic effects on ventricular repolarization: Evidence of weaker antagonism in hostile type A men Circulation 85 1992 2045
19. A.H. Glassman Smoking, smoking cessation, and major depression JAMA 264 1990 1546
20. E. Hartka Meta-analysis of depressive symptomatology and alcohol consumption over time British Journal of Addiction 86 1991 1283
21. K.F. Helmers Hostility and myocardial ischemia in coronary artery disease patients: Evaluation by gender and ischemic index Psychosom Med 55 1993 29
22. G. Ironson Effects of anger on left ventricular ejection fraction in coronary artery disease Am J Cardiol 70 1992 281
23. G.A. Kaplan J.E. Kiel Socioeconomic factors and cardiovascular disease: A review of the literature Circulation 88 1993 1973
24. G. Ladwig Post-infarction depression and incomplete recovery six months after acute myocardial infarction Lancet 343 1994 20
25. M.W. Ketterer Secondary prevention of ischemic heart disease: The case for aggressive behavioral monitoring and intervention Psychosomatics 34 1993 478 484
26. A. Littman M. Fava K. McKool The use of buspirone in the treatment of stress, hostility, and type A behavior in cardiac patients: An open trial Psychother Psychosom 59 1993 107
27. A.B. Littman Review of psychosomatic aspects of cardiovascular disease Psychother Psychosom 60 1993 148
28. A.B. Littman Prevention of disability due to cardiovascular diseases Heart Disease and Stroke 2 1993 274
29. Littman AB, et al: Behavioral medicine in consultation-liaison psychiatry. In Rundell J, Wise M (eds): American Psychiatric Press Textbook of Consultation-Liaison Psychiatry, ed 1. Washington, American Psychiatric Press, in press
30. P.T. Mehlman Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates Am J Psychiatry 152 1995 907
31. R. Mermelstein Social support and smoking cessation and maintenance J Consult Clin Psychol 54 1986 447
32. E.V. Nunes K.A. Frank D.S. Kornfeld Psychologic treatment for the type A behavior pattern and coronary artery disease: A meta-analysis of the literature Psychosom Med 48 1987 159 173
33. D. Ornish Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial Lancet 336 1990 129
34. D. Ornish Can lifestyle changes reverse coronary atherosclerosis? Four-year results of the Lifestyle Heart Trial. Abstracts from the 66th Scientific Sessions of the American Heart Association Circulation 88 1993 i-385
35. K. Orth-Gomer A.-L. Unden Type A behavior, social support, and coronary risk: Interaction and significance for mortality in cardiac patients Psychosom Med 52 1990 59
36. D.R. Ragland R.J. Brand Coronary heart disease mortality in the Western Collaborative Group Study: Follow-up experience of 22 years N Engl J Med 318 1988 65
37. M.J. Raleigh Dominant social status facilitates the behavioral effects of serotonergic agonists Brain Res 348 1985 274
38. T. Rechlin The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability J Clin Psychopharmacol 14 1994 392
39. M. Rosal J. Downing A.B. Littman Sexual functioning post-myocardial infarction: Effects of beta-blockers, psychological status and safety information J Psychosom Res 38 1994 655
40. J.F. Rosenbaum The psychopharmacology of social phobia and comorbid disorders Bull Menninger Clin 58 1994 a67
41. A. Roy Acting out hostility in normal volunteers: Negative correlation with levels of 5-HIAA in cerebrospinal fluid Psychiatry Res 24 1989 187
42. W. Ruberman Psychosocial influences on mortality after myocardial infarction N Engl J Med 311 1984 552
43. L.W. Scherwitz Hostility and health behaviors in young adults: The CARDIA study Am J Epidemiol 136 1992 136
44. 2 adrenergic receptor/adenylate cylase activity Psychosom Med 56 1994 174
45. I.C. Siegler Hostility during late adolescence predicts coronary risk factors at midlife Am J Epidemiol 136 1992 146
46. S.L. Sigal Potentiation of the vasospastic response to angioplasty by pretreatment with fluoxetine Arterioscler Thromb 13 1993 907
47. T. Silverstone Drugs, appetite, and obesity: A personal odyssey Int J Obes Relat Metab Disord 16 1992 s49
48. Sloan R, et al: Cardiovascular autonomic control and hostility. Am J Cardiol, in press
49. E.C. Suarez R.B. Williams Situational determinants of cardiovascular and emotional reactivity in high and low hostile men Psychosom Med 51 1989 404
50. Suarez EC, et al: Hostility-related differences in urinary excretion rates of catecholamines. Paper presented at annual meeting, Society for Psychophysiological Research, Chicago, III, 1992
51. P. Turner Benefit:risk consideration in long-term therapy with dexfenfluramine Int J Obes Relat Metab Disord 16 1992 s15
52. M. Virkunnen Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers Arch Gen Psychiatry 51 1994 28
53. R. Vieth Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics Arch Gen Psychiatry 51 1994 411
54. Wells The function and well-being of depressed patients: Results from the medical outcome study JAMA 262 1989 914
55. C.A. Williams The Edgecomb County High Blood Pressure Control Program: III. Social support, social stressors, and treatment dropout Am J Public Health 75 1985 483
56. R.B. Williams Neurobiology, cellular and molecular biology, and psychosomatic medicine Psychosom Med 56 1994 315
57. R.B. Williams M.A. Chesney Psychosocial factors and prognosis in established coronary artery disease: The need for research on interventions JAMA 270 1993 1860
58. R.B. Williams Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease JAMA 267 1992 520
59. S. Yusuf Overview of results of randomized clinical trials in heart disease: I. Treatments following myocardial infarction JAMA 260 1988 2088